Influence of imprecision on ROC curve analysis for cardiac markers.

Published

Journal Article

BACKGROUND: There has been considerable debate regarding the impact of assay imprecision on the performance of cardiac biomarkers for diagnosis of acute coronary syndromes (ACS) and risk stratification for future adverse cardiac events. METHODS: Using existing data from 2 published clinical trials, we used a resampling method to statistically introduce 5%, 10%, and 20% imprecision to results for B-type natriuretic peptide (BNP) and cardiac troponin I (cTnI) and examined its impact on ROC curve analysis. RESULTS: Superimposition of artificial imprecision produced no significant difference in the area under the ROC curve observed for BNP for diagnosis of heart failure or for cTnI for 30-day risk stratification of patients with ACS. CONCLUSION: Assay imprecision does not appear to be a critical determinant in the interpretation of cardiac marker results for patients with heart disease.

Full Text

Duke Authors

Cited Authors

  • Kupchak, P; Wu, AHB; Ghani, F; Newby, LK; Ohman, EM; Christenson, RH

Published Date

  • April 2006

Published In

Volume / Issue

  • 52 / 4

Start / End Page

  • 752 - 753

PubMed ID

  • 16469856

Pubmed Central ID

  • 16469856

International Standard Serial Number (ISSN)

  • 0009-9147

Digital Object Identifier (DOI)

  • 10.1373/clinchem.2005.064477

Language

  • eng

Conference Location

  • England